To our knowledge, these findings provide the first evidence of individualized treatment effect estimates for CPAP therapy in obstructive sleep apnea. These results also highlight the potential for precision medicine approaches to guide treatment decisions, reduce cardiovascular disease risk, and avoid harm in susceptible individuals.
Cohen et al. (Fri,) studied this question.